Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy

Clinical Nephrology

Volumn 58, Issue 4, 2002, Pages 267-274

  Branten, A J W ^a   Klasen, I S ^a   Wetzels, J F M ^a   Feith, G ^a   den Hartog, M ^a   van Hamersvelt, H ^a   Hollander, A ^a   Jansen, J ^a   Koolen, M ^a   Kloke, H ^a   van Leusen, R ^a   Luckers, T ^a   Smeets, R ^a   Verstappen, V ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fish oil; IgA nephropathy; Proteinuria; Tubulo interstitial inflammation

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA 2 MICROGLOBULIN; BICARBONATE; CIMETIDINE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOCOSAHEXAENOIC ACID; FISH EPA; FISH OIL; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; MONOCYTE CHEMOTACTIC PROTEIN 1; OMEGA 3 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DOSE RESPONSE; DRUG MECHANISM; FEMALE; GLOMERULITIS; GLOMERULUS FILTRATION; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; INTERSTITIAL NEPHRITIS; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; MALE; MEAN ARTERIAL PRESSURE; MOLECULAR WEIGHT; PROTEINURIA; SIDE EFFECT;

EID: 0036791615     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp58267     Document Type: Article

References (36)

1. Alvestrand A, Gutierrez A, Bucht H, Bergstrom J 1988 Reduction of blood pressure retards the progression of chronic renal failure in man. Nephrol Dial Transplant 3: 624-631
2. Bennet WM, Walker RG, Kincaid-Smith P 1989 Treatment of IgA nephropathy with eiciosapentanoic acid (EPA): a two-year prospective trial. Clin Nephrol 31: 128-131
3. Cartwright IJ, Pockley AG, Galloway JH, Greaves M, Presten FE 1985 The effects of dietary omega-3 poly-unsaturated fatty acids on erythrocyte membrane phospholipids erythrocyte deformability and blood viscosity in healthy volunteers. Atherosclerosis 55: 267-281
4. Cattran DC, Greenwood C, Ritchie S 1994 Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe IgA nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis 23: 247-254
5. Cheng IKP, Chan PCK, Chan MK 1990 The effect of fish oil dietary supplement on the progression of mesangial IgA glomerulonephritis. Nephrol Dial Transplant 5: 241-246
6. Clark WF, Parbtani A, Huff W, Reid B, Holub BJ, Falardean P 1989 Omega-3 fatty acid dietary supplementation in systemic lupus erythromatosus. Kidney Int 36: 653-660
7. Clark WF, Parbtani A, Naylor CD, Levinton CM, Muirhead N, Spanner E, Huff W, Philbrick D, Holub BJ 1993b Fish oil in lupus nephritis: clinical findings and methodological implications. Kidney Int 44: 75-86
8. Clark WF, Parbtani A, Philbrick D, McDonald JWD, Smallbone B, Reid B, Holub BJ, Kreeft J 1990 Comparative efficacy of dietary treatments on renal function in rats with subtotal nephrectomy: renal polyunsaturated fatty acid incorporation and prostaglandin excretion. Clin Nephrol 33: 25-34
9. Clark WF, Parbtani A, Philbrick D, Spanner E, Huff W, Holub BJ 1993a Dietary protein restriction versus fish oil supplementation in the chronic remnant nephron model. Clin Nephrol 39: 295-304
10. D'Amico G, Minetti L, Ponticelli C, Fellin G, Ferrario F, Barbiano di Belgioioso G, Imbasciati E, Ragni A, Bertoli S, Fogazzi G, Duca G 1986 Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med 228: 363-378
11. de Caterina R, Caprioli R, Giannessi D, Sicari R, Galli C, Lazzerini G, Bernini W, Carr L, Rindi P 1993 n-3 fatty acids reduce proteinuria in patients with chronic glomerular disease. Kidney Int 44: 843-850
12. Donadio JV, Bergstralh EJ, Offord KP, Spencer DC, Holley KE 1994 A controlled trial of fish oil in lgA nephropathy. N Engl J Med 331: 1194-1199
13. Donadio JV, Grande JP, Bergstralh EJ, Dart RA, Larson TS, Spencer DC, for the mayo nephrology collaborative group 1999 The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. J Am Soc Nephrol 10: 1772-1777
14. Eberhard OK, Potschick H, Neumann KH, Kliem V, Brunkhorst R 1999 Short- and long-term effects of fish oil on proteinuria, morphology and renal hemodynamics in the Milan normotensive rat model of spontaneous glomerulosclerosis. Kidney Blood Press Res 22: 128-134
15. Elving LD, Bakkeren JAJM, Jansen MJH, de Kat Angelino CM, de Nobel E, van Munster PJJ 1989 Screening for microalbuminuria in patients with diabetes mellitus: frozen storage of urine samples decreases their albumin content. Clin Chem 35: 308-310
16. Grimble RF, Tappia PS 1995 Modulatory influence of unsaturated fatty acids on the biology of tumour necrosis factor-α. Biochem Soc Transact 23: 282-287
17. Hamazaki T, Tateno S, Shishido H 1984 Eicosapentaenoic acid and IgA nephropathy. Lancet I: 1017-1018
18. Hilbrands LB, Artz MA, Wetzels JFM, Koene RAP 1991 Cimetidine improves the reliability of creatinine as a marker of glomerular filtration. Kidney Int 40: 1171-1176
19. Ibels LS, Gyory AZ 1994 IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease and a review of the literature. Medicine 73: 79-102
20. Jacobs EMG, Vervoort G, Branten AJW, Klasen I, Smits P, Wetzels JFM 1999 Atrial natriuretic peptide increases albuminuria in type I diabetic patients: evidence for blockade of tubular protein reabsorption. Eur J Clin Invest 29: 109-115
21. Johnston PA, Brown JS, Braumholtz DA, Davison AM 1992 Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy. A report from the MRC glomerulonephritis registry. Q J Med 304: 619-627
22. Knapp HR, Fitzgerald GA 1989 The antihypertensive effects of fish oil. N Engl J Med 320: 1037-1043
23. Lee TH, Mencia-Huerter JM, Shih C, Correy EJ, Lewis RA, Austen KF 1984 Effects of exogenous arachidonic, eicosapentaenoic and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore activated human neutrophils. J Clin Invest 74: 1922-1933
24. Maachi K, Berthoux P, Burgard G, Alamartine E, Berthoux F 1995 Results of a 1-year randomized controlled trial with omega-3 fatty acid fish oil in renal transplantation under triple immunosuppressive therapy. Transplant Proc 27: 846-849
25. Manitius J, Sulikowska B, Fox J, Jakubowski Z, Ludwiczak E, Lysiak-Szydlowska W, Rutkowski B 1997 The effect of dietary enrichment with fish oil on urinary excretion of β-N-acetyl-beta-D-glucosaminidase and renal function in proteinuric patients with primary glomerulopathies. Int Urol Nephrol 29: 489-495
26. Nolin L, Courteau M 1999 Management of IgA nephropathy: evidence-based recommendations. Kidney Int Suppl 70: S56-S62
27. Pettersson EE, Rekola S, Berglund L, Sundqvist KG, Angelin B, Diczfalusy U, Bjorkhem I, Bergstrom J 1994 Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: a prospective, double-blind, randomized study. Clin Nephrol 41: 183-190
28. Phillipson BE, Rothrock DW, Connor RE, Harris WS, Illingworth DR 1985 Reduction of plasma lipids, lipoproteins and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 312: 1210-1216
29. Radford JMG, Donadio JJV, Bergstralh EJ, Grande JP 1997 Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 8: 199-207
30. Reichert LJM, Koene RAP, Wetzels JFM 1997 Urinary IgG excretion as a prognostic factor in idiopathic membranous nephropathy. Clin Nephrol 48: 79-84
31. Robinson DR, Prickett JD, Makoul GT, Steinberg AD, Colvin RB 1986 Dietary fish oil reduces progression of established renal disease in (NZBxNZW)F1 mice and delays renal disease in BXSB and MRL/1 strains. Arthritis Rheum 29: 539-546
32. Rovin BH, Doe N, Tan LC 1996 Monocyte chemoattractant protein-1 levels in patients with glomerular disease. Am J Kidney Dis 27: 640-646
33. Stoof TJ, Korstanje MJ, Bilo H, Starink ThM, Hulsmans RFHJ, Donker A 1989 Does fish oil protect renal function in cyclosporin-treated psoriasis patients? J Intern Med 226: 437-441
34. Weise WJ, Natori Y, Levine JS, O'Meara Y, Minto AW, Manning EC, Goldstein DJ, Abrahamson DR, Salant DJ 1993 Fish oil has protective and therapeutic effects on proteinuria in passive Heymann nephritis. Kidney Int 43: 359-368
35. Wa T-H, Wu S-C, Huang T-P, Yu C-L, Tsai C-Y 1996 Increased excretion of tumor necrosis factor alpha and interleukin 1β in urine from patients with IgA nephropathy and Schönlein-Henoch purpura. Nephron 74: 79-88
36. Zaltzman JS, Whiteside C, Cattran DC, Lopez FM, Logan AG 1996 Accurate measurement of impaired glomerular filtration using single-dose oral cimetidine. Am J Kidney Dis 27: 504-511